subject area of

• A Summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses  Other Publication
• Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study  Academic Article
• Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study  Academic Article
• Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector  Academic Article
• Analysis of inhibitor binding in influenza virus neuraminidase  Academic Article
• Antiviral distribution data--a potential syndromic surveillance system to assist pandemic health service operational planning.  Academic Article
• Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia  Academic Article
• Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study  Academic Article
• Chenodeoxycholic acid from bile inhibits influenza A virus replication via blocking nuclear export of viral ribonucleoprotein complexes  Academic Article
• Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment  Academic Article
• Community-Based Provision of Direct-Acting Antiviral Therapy for Hepatitis C: Study Protocol and Challenges of a Randomized Controlled Trial  Academic Article
• Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵ  Academic Article
• Delivering the hepatitis C cure to Aboriginal people: documenting the perspectives of one Aboriginal Health Service  Academic Article
• Design of potential anti-HIV agents. 1. Mannosidase inhibitors  Academic Article
• Direct-acting antiviral agents for HCV infection affecting people who inject drugs  Academic Article
• Direct-acting antiviral treatment for HCV  Letter
• Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis  Academic Article
• Distribution of vaccine/antivirals and the ‘least spread line’ in a stratified population  Academic Article
• Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: A multicenter clinical experience  Academic Article
• Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study  Academic Article
• Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis  Academic Article
• Elimination of Hepatitis C Virus in Australia: Laying the Foundation  Academic Article
• Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy  Academic Article
• Eradicating hepatitis C: the need for a public health response  Academic Article
• Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study  Academic Article
• Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation  Academic Article
• Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study  Academic Article
• HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs  Academic Article
• HIV-1 infection of human macrophages directly induces viperin which inhibits viral production  Academic Article
• Hepatitis C transmission and treatment as prevention - The role of the injecting network  Academic Article
• Hepatitis C treatment as prevention: evidence, feasibility, and challenges  Academic Article
• Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse  Academic Article
• Hepatitis C: an economic evaluation of extended treatment with interferon  Academic Article
• Hepatitis c virus reinfection and spontaneous clearance of reinfection - The InC³ study  Conference Paper
• Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression  Academic Article
• Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization?  Academic Article
• Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3  Academic Article
• ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response  Academic Article
• Influenza outbreaks in aged-care facilities: Staff vaccination and the emerging use of antiviral therapy  Academic Article
• Inhibition of proanthocyanidin A2 on porcine reproductive and respiratory syndrome virus replication in vitro  Academic Article
• Innate immune pathways in afferent lymph following vaccination with poly(I:C)-containing liposomes  Academic Article
• Interferon-stimulated genes as enhancers of antiviral innate immune signaling  Academic Article
• Letter: new treatments for hepatitis C have implications for quality of life in people who inject drugs  Letter
• Letter: the rs12979860 and ss469415590 polymorphisms of IFNL4 gene are in strong linkage disequilibrium in Caucasian patients with chronic hepatitis C  Academic Article
• Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre  Academic Article
• Management of acute HCV infection in the era of direct-acting antiviral therapy  Academic Article
• Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, Australia  Academic Article
• Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012  Academic Article
• New hepatitis C antiviral treatments eliminate the virus  Letter
• Now, later or never? Challenges associated with hepatitis C treatment  Academic Article
• Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009  Academic Article
• Oyster viperin retains direct antiviral activity and its transcription occurs via a signalling pathway involving a heat-stable haemolymph protein  Academic Article
• Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy  Academic Article
• Pharmacies dispensing opioid substitution therapy also play a role in hepatitis C virus elimination  Letter
• Pharmacy-led hepatitis C treatment pathways to help ensure elimination  Letter
• Platycodin D suppresses type 2 porcine reproductive and respiratory syndrome virus in primary and established cell lines  Academic Article
• Polymers in the Delivery of siRNA for the Treatment of Virus Infections  Academic Article
• Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic  Academic Article
• Primed for success: Oyster parents treated with poly(I:C) produce offspring with enhanced protection against Ostreid herpesvirus type I infection  Academic Article
• Recognition by host nuclear transport proteins drives disorder-to-order transition in Hendra virus V  Academic Article
• Recognition of Hepatitis C Virus Coinfection in HIV-Positive Injecting Drug Users in Asia  Academic Article
• Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia  Academic Article
• Ribosome-inactivating proteins: Current status and biomedical applications  Academic Article
• SYNTHESIS AND BIOLOGICAL EVALUATION OF N-SALICYLOYL-N-BENZYLTHIOUREA AND 2,2-DIMETHYL-4-OXO-6-METHOXYBENZO-1,3-DIOXIN  Academic Article
• Saikosaponin a inhibits influenza A virus replication and lung immunopathology  Academic Article
• Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial  Academic Article
• Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcome  Academic Article
• Stachyonic Acid: A Dengue Virus Inhibitor from Basilicum polystachyon  Academic Article
• Strategies to manage hepatitis C virus infection disease burden - volume 3  Academic Article
• Structural Studies of the Resistance of Influenza Virus Neuramindase to Inhibitors  Academic Article
• Structure of a dideoxynucleoside active against the HIV (AIDS) virus  Academic Article
• The Edinburgh cohort of HIV-positive injecting drug users at 10 years after infection  Academic Article
• The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia  Academic Article
• The RNA-Dependent-RNA Polymerase, an Emerging Antiviral Drug Target for the Hendra Virus.  Academic Article
• The hepatitis B epidemic and the urgent need for cure preparedness  Comment
• The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment  Academic Article
• The role of viperin in the innate antiviral response  Academic Article
• The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism  Academic Article
• Uptake of direct-acting antiviral treatment for chronic hepatitis C in Australia  Academic Article
• Use of a Flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compounds  Academic Article
• Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C  Academic Article
• “Don’t think I’m going to leave you over it”: Accounts of changing hepatitis C status among couples who inject drugs  Academic Article
• “I'm obviously not dying so it's not something I need to sort out today”: Considering hepatitis C treatment in the era of direct acting antivirals  Academic Article